Bright Minds Biosciences Inc. (DRUG)
$51.36-4.91%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $503M
- Beta
- 0.09
- P/E (TTM)
- -25.75
- Short % float
- 14.45%
- Days to cover
- 8.5
- SI change
- -5.3%
- 1W
- +6.45%
- 1M
- -18.96%
- vs SPY 1W
- +6.58%
- vs SPY 1M
- -21.47%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on DRUG?
- LOPJLB’s latest quantitative signal on Bright Minds Biosciences Inc. (DRUG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is DRUG in?
- Bright Minds Biosciences Inc. (DRUG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Bright Minds Biosciences Inc. (DRUG) do?
- Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical tria…